Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v2-FR
Language French French
Date Updated 2017-10-16 2017-08-24
Drug Identification Number 02403374 02403374
Brand name APO-ROSIGLITAZONE APO-ROSIGLITAZONE
Common or Proper name ROSIGLITAZONE ROSIGLITAZONE
Company Name AA PHARMA INC AA PHARMA INC
Ingredients ROSIGLITAZONE ROSIGLITAZONE
Strength(s) 4MG 4MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code A10BG A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-08-21 2017-08-21
Estimated end date 2017-10-16 2017-10-16
Actual end date 2017-10-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments